One of their key attributes is their mobility to sites of inflammation, infection, and tumors. This trait garnered the attention of researchers who developed therapies to leverage macrophages’ ...

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...

umors use chemokine signals to draw monocytes and tissue-resident macrophages into the tumor microenvironment, where the cells become tumor-associated macrophages (TAMs). Once believed to be wholly ...

They principally investigated macrophages, an immune cell which normally fights infection and kills microorganisms. However, cancer can corrupt macrophages—suppressing their ability to trigger ...

CAR-T therapy faces significant challenges in treating solid tumors such as lung cancer. Macrophages, a type of immune cell, have an inherent ability to infiltrate solid tumors more effectively ...

They principally investigated macrophages, an immune cell which normally fights infection and kills microorganisms. However, cancer can corrupt macrophages – suppressing their ability to trigger ...

We found an increased frequency of pro-tumor immune cells—known as M2-like tumor-associated macrophages (TAMs), which proportionally increased with tumor size during tumor progression.

CAR-T therapy faces significant challenges in treating solid tumors such as lung cancer. Macrophages, a type of immune cell, have an inherent ability to infiltrate solid tumors more effectively ...